ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population

Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients

(2014) Axel Muendlein et al.   ATHEROSCLEROSIS

ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial

(2011) Melissa C Smart-Halajko et al.   BMC Medical Genetics

Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase Activity

(2011) Xia Lei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Relationship Between Plasma Angiopoietin-like Protein 4 Levels, Angiopoietin-like Protein 4 Genotype, and Coronary Heart Disease Risk

(2010) Melissa C. Smart-Halajko et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and Function

(2009) Wu Yin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample

(2009) Marius R. Robciuc et al.   JOURNAL OF LIPID RESEARCH

ANGPTL4 E40K and T266M

(2008) Philippa J. Talmud et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Association of Genetic Variation on Chromosome 9p21 With Susceptibility and Progression of Atherosclerosis

(2008) Shu Ye et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY